Crespo-Rodriguez, E., Bergerhoff, K., Bozhanova, G., Foo, S., Patin, E. C., Whittock, H., Buus, R., Haider, S., Muirhead, G., Thway, K., Newbold, K., Coffin, R. S., Vile, R. G., Kim, D., McLaughlin, M., Melcher, A. A., Harrington, K. J., & Pedersen, M. (2020). combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer. Journal for immunotherapy of cancer, 8(2), . http://access.bl.uk/ark:/81055/vdc_100127562797.0x000032